PMC:7402624 / 3578-3779
Annnotations
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T28 | 132-138 | Body_part | denotes | plasma | http://purl.org/sig/ont/fma/fma62970 |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
89 | 57-66 | Species | denotes | SARS-CoV2 | Tax:2697049 |
93 | 67-76 | Disease | denotes | infection | MESH:D007239 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T27 | 57-61 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
T28 | 67-76 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T44 | 3-5 | http://purl.obolibrary.org/obo/CLO_0050509 | denotes | 27 |
T45 | 132-138 | http://purl.obolibrary.org/obo/UBERON_0001969 | denotes | plasma |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T27 | 8-110 | Sentence | denotes | Furthermore, neutralizing antibodies can control SARS-CoV2 infection in vitro and in vivo (4, 28, 29). |